SlideShare a Scribd company logo
Dose Response Relationship & Therapeutic Index Dr Rizwan
quantal (cumulative) D/R curve tachyphylaxis graded (quantitative) D/R curve therapeutic index potency median toxic dose (TD50) efficacy (effectiveness) median effective dose (ED50) dose/response (D/R) Objectives
[object Object]
Systemic description of the magnitude of the  effect of a drug  as a function of the dose (very low to very high)
Dose response curves ,[object Object]
[object Object],[object Object],[object Object],[object Object]
Shape of the curve ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
Threshold ,[object Object],[object Object]
BIOLOGICAL STIMULUS PERCENT RECEPTOR OCCUPANCY 0% 100% BIOLOGICAL RESPONSE RECEPTOR RESERVE TRETHOLD 0% 100% Max Effect Threshold Effect Schematic representation of the relationship between threshold, receptor  reserve, receptor occupancy, biological stimulus and biological response
 
When a threshold is difficult to determine ,[object Object],Why?
[object Object],[object Object],A  relatively flat slope suggest  that effect of an  increasing dose is  minimal
Dose Response Curve ,[object Object]
 
[object Object],[object Object],[object Object],[object Object]
 
Is there any relationship between shape of curve and potency ,[object Object]
Reason for steep curve ,[object Object],[object Object],[object Object]
 
Used to measure ,[object Object],[object Object],[object Object]
POTENCY CONCENTRATION (EC50) OR DOSE (ED50)  OF A DRUG  REQUIRED TO PRODUCE  50% OF THAT DRUG’S MAXIMUM EFFECT
X 0 Average  Response  Magnitude DRUG DOSE Potency HI ,[object Object],A B
DRUG DOSE X 0 Average  Response  Magnitude HI LO Maximum Efficacy ,[object Object],A B
[D] (concentration units) % Maximal Effect 0.01 0.10 1.00 10.00 100.00 1000.00 0.0 0.2 0.4 0.6 0.8 1.0 Partial agonist Full Agonist Partial agonist PARTIAL AGONISTS - EFFICACY Even though drugs may occupy the same # of receptors, the magnitude of their effects may differ.
 
 
Example  ,[object Object],BUT
[object Object],[object Object]
Difference between the 3 drugs is their   ,[object Object],ISOPROTERENOL  >  EPINEPHRINE  >  NOR EPINEPHRINE
[object Object],[object Object],[object Object]
What is the difference between Quantal and graded dose-response curves?
Graded (Quantitative) dose-effect relationships   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Graded dose response curves show effects  on a continuous scale And the intensity of the effect  is proportional to the dose
Exposure to ethanol  Graded responses between no effect and death
Requirements   ,[object Object],[object Object]
Problem   ,[object Object]
Plot of the contraction of the intestinal smooth muscle in response to varied doses of acetylcholine
Observation   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Quantal (All-or-none; binary) dose-effect relationships   ,[object Object],[object Object]
All or None ,[object Object],[object Object],[object Object],[object Object]
 
Purpose   ,[object Object]
Defined specific effect and degree of response  -- ,[object Object],[object Object],[object Object],[object Object]
Problem   ,[object Object],[object Object]
Titration   ,[object Object],[object Object],[object Object],[object Object]
Titration of each individual  Administer increasing doses of drug to each individual until a response is elicited, then note the dose.  Do this for all members of the test population.  very impractical  ------serious conceptual disadvantages,  e.g., multiple doses of drug may produce a false effect compared to a single exposure to a larger dose.  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Shape of curve   ,[object Object],[object Object]
Description of data   ,[object Object]
Construction of  quantal  (binary) dose-effect curves   ,[object Object],[object Object]
Method A: Titrate each animal   Sample experiment ,[object Object],[object Object],[object Object],[object Object],[object Object]
BELL SHAPED CURVE majority of responders in the middle mean response is approx. 110 mg/kg fewer responders at the end of bell curve (expected) known as  biological variability responders at the far left of the mean are typically  hypersusceptible whereas those at the far right are  resistant
Comments   ,[object Object],[object Object],[object Object]
Method B -- Titration of groups ,[object Object],[object Object]
Sample experiment  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cumulative quantal dose response plot
 
Both curves provide ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Quantal D/R curves  used to define  ,[object Object],[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],Decision Making ,[object Object],[object Object],[object Object],LD 50 ED 50
BIOLOGICAL STIMULUS PERCENT RECEPTOR OCCUPANCY 0% 100% BIOLOGICAL RESPONSE RECEPTOR RESERVE TRETHOLD 0% 100% Max Effect Threshold Effect Schematic representation of the relationship between threshold, receptor  reserve, receptor occupancy, biological stimulus and biological response
[object Object],100 50 0 DRUG DOSE 0 X ED LD % subjects TI = LD 50 / ED 50
[object Object],100 50 0 DRUG DOSE 0 X ED LD % subjects TI = LD 50 / ED 50

More Related Content

What's hot

Mechanism of drug action
Mechanism of drug actionMechanism of drug action
Mechanism of drug actionDr.Vijay Talla
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicology
priyanka.p. Nayak
 
Combined effects of Drugs, Pharmacology
Combined effects of Drugs, PharmacologyCombined effects of Drugs, Pharmacology
Combined effects of Drugs, Pharmacology
Dhruva Sharma
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
mohamed sanooz
 
Pharmacodynamics PPT
Pharmacodynamics PPTPharmacodynamics PPT
Pharmacodynamics PPT
Dr. Vijay Prasad
 
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
http://neigrihms.gov.in/
 
Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)
Dr Renju Ravi
 
Therapeutic index
Therapeutic indexTherapeutic index
Therapeutic index
Afra Fathima
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptor
Dr. Siddhartha Dutta
 
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX-
DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX-
Saajida Sultaana
 
Drug Response.pptx
Drug Response.pptxDrug Response.pptx
Drug Response.pptx
FarazaJaved
 
Factors modifying drug action, efficacy & potency
Factors modifying drug action, efficacy & potencyFactors modifying drug action, efficacy & potency
Factors modifying drug action, efficacy & potencyBADAR UDDIN UMAR
 
Introduction To Toxicology updated.pptx
Introduction To Toxicology updated.pptxIntroduction To Toxicology updated.pptx
Introduction To Toxicology updated.pptx
Dr. Sarita Sharma
 
2. dose resp relationsp presentsn copy - copy
2. dose resp relationsp presentsn   copy - copy2. dose resp relationsp presentsn   copy - copy
2. dose resp relationsp presentsn copy - copysuniu
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
Dr. Pramod B
 
Toxicology and its types by Kashikant Yadav
Toxicology and its types by Kashikant YadavToxicology and its types by Kashikant Yadav
Toxicology and its types by Kashikant Yadav
Kashikant Yadav
 
Types of receptors
Types of receptorsTypes of receptors
Types of receptors
DrSahilKumar
 
Principles of Toxicology
Principles of ToxicologyPrinciples of Toxicology
Principles of Toxicology
vadivelan2017
 

What's hot (20)

Mechanism of drug action
Mechanism of drug actionMechanism of drug action
Mechanism of drug action
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicology
 
Combined effects of Drugs, Pharmacology
Combined effects of Drugs, PharmacologyCombined effects of Drugs, Pharmacology
Combined effects of Drugs, Pharmacology
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
 
Pharmacodynamics PPT
Pharmacodynamics PPTPharmacodynamics PPT
Pharmacodynamics PPT
 
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...
 
Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)
 
Therapeutic index
Therapeutic indexTherapeutic index
Therapeutic index
 
INTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGYINTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGY
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptor
 
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX-
DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-DRUG RESPONSELD50,ED50 ANDTHERAPEUTIC INDEX-
DRUG RESPONSE LD50, ED50 AND THERAPEUTIC INDEX-
 
Drug Response.pptx
Drug Response.pptxDrug Response.pptx
Drug Response.pptx
 
Factors modifying drug action, efficacy & potency
Factors modifying drug action, efficacy & potencyFactors modifying drug action, efficacy & potency
Factors modifying drug action, efficacy & potency
 
Bioassay
BioassayBioassay
Bioassay
 
Introduction To Toxicology updated.pptx
Introduction To Toxicology updated.pptxIntroduction To Toxicology updated.pptx
Introduction To Toxicology updated.pptx
 
2. dose resp relationsp presentsn copy - copy
2. dose resp relationsp presentsn   copy - copy2. dose resp relationsp presentsn   copy - copy
2. dose resp relationsp presentsn copy - copy
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Toxicology and its types by Kashikant Yadav
Toxicology and its types by Kashikant YadavToxicology and its types by Kashikant Yadav
Toxicology and its types by Kashikant Yadav
 
Types of receptors
Types of receptorsTypes of receptors
Types of receptors
 
Principles of Toxicology
Principles of ToxicologyPrinciples of Toxicology
Principles of Toxicology
 

Similar to Lecture 2 Dose Response Relationship 1

Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
Heena Parveen
 
dose response in epidemilogy curves.pptx
dose response in epidemilogy curves.pptxdose response in epidemilogy curves.pptx
dose response in epidemilogy curves.pptx
Thomas844346
 
Dose response curvevpp
Dose response curvevppDose response curvevpp
Dose response curvevpp
Virupanagouda patil
 
Dose Response Phenomenon.pptx
Dose Response Phenomenon.pptxDose Response Phenomenon.pptx
bioassay.pdf
bioassay.pdfbioassay.pdf
bioassay.pdf
ChijiokeNsofor
 
Bioassay ppt by dr sumit
Bioassay ppt by dr sumitBioassay ppt by dr sumit
Bioassay ppt by dr sumit
Sumit Kumar
 
Determination of potency metronidazole
Determination of potency metronidazoleDetermination of potency metronidazole
Determination of potency metronidazole
Atai Rabby
 
Unit 10 +11 dose response relationship (PC- 520)
Unit 10 +11 dose response relationship (PC- 520)Unit 10 +11 dose response relationship (PC- 520)
Unit 10 +11 dose response relationship (PC- 520)
PHARMA IQ EDUCATION
 
BIOASSAYS.pptx
BIOASSAYS.pptxBIOASSAYS.pptx
BIOASSAYS.pptx
Priyanka Saroj
 
Consequences of drug receptor interactions
Consequences of drug receptor interactionsConsequences of drug receptor interactions
Consequences of drug receptor interactions
Jannatul Ferdoush
 
Pharmacodynamics 2020
Pharmacodynamics 2020 Pharmacodynamics 2020
Pharmacodynamics 2020
adnan mansour
 
branch of pharmacology dedicated to determine the fate of substances administ...
branch of pharmacology dedicated to determine the fate of substances administ...branch of pharmacology dedicated to determine the fate of substances administ...
branch of pharmacology dedicated to determine the fate of substances administ...
adnan mansour
 
Pharmacodynamics.2020
Pharmacodynamics.2020Pharmacodynamics.2020
Pharmacodynamics.2020
adnan mansour
 
Overview of Pharmacodynamics
Overview of PharmacodynamicsOverview of Pharmacodynamics
Bioassay.pptx
Bioassay.pptxBioassay.pptx
Bioassay.pptx
Kaviya Santhakumar
 
bioassay-converted.pptx
bioassay-converted.pptxbioassay-converted.pptx
bioassay-converted.pptx
ChijiokeNsofor
 
Dose-Response of drugs towards the human body
Dose-Response of drugs towards the human bodyDose-Response of drugs towards the human body
Dose-Response of drugs towards the human body
Tabassum Saher
 
Expt. 4 DRC of acetylcholine using frog rectus abdominis muscle
Expt. 4 DRC of acetylcholine using frog rectus abdominis muscleExpt. 4 DRC of acetylcholine using frog rectus abdominis muscle
Expt. 4 DRC of acetylcholine using frog rectus abdominis muscle
VISHALJADHAV100
 
Ic50
Ic50Ic50

Similar to Lecture 2 Dose Response Relationship 1 (20)

DRC.pdf
DRC.pdfDRC.pdf
DRC.pdf
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
 
dose response in epidemilogy curves.pptx
dose response in epidemilogy curves.pptxdose response in epidemilogy curves.pptx
dose response in epidemilogy curves.pptx
 
Dose response curvevpp
Dose response curvevppDose response curvevpp
Dose response curvevpp
 
Dose Response Phenomenon.pptx
Dose Response Phenomenon.pptxDose Response Phenomenon.pptx
Dose Response Phenomenon.pptx
 
bioassay.pdf
bioassay.pdfbioassay.pdf
bioassay.pdf
 
Bioassay ppt by dr sumit
Bioassay ppt by dr sumitBioassay ppt by dr sumit
Bioassay ppt by dr sumit
 
Determination of potency metronidazole
Determination of potency metronidazoleDetermination of potency metronidazole
Determination of potency metronidazole
 
Unit 10 +11 dose response relationship (PC- 520)
Unit 10 +11 dose response relationship (PC- 520)Unit 10 +11 dose response relationship (PC- 520)
Unit 10 +11 dose response relationship (PC- 520)
 
BIOASSAYS.pptx
BIOASSAYS.pptxBIOASSAYS.pptx
BIOASSAYS.pptx
 
Consequences of drug receptor interactions
Consequences of drug receptor interactionsConsequences of drug receptor interactions
Consequences of drug receptor interactions
 
Pharmacodynamics 2020
Pharmacodynamics 2020 Pharmacodynamics 2020
Pharmacodynamics 2020
 
branch of pharmacology dedicated to determine the fate of substances administ...
branch of pharmacology dedicated to determine the fate of substances administ...branch of pharmacology dedicated to determine the fate of substances administ...
branch of pharmacology dedicated to determine the fate of substances administ...
 
Pharmacodynamics.2020
Pharmacodynamics.2020Pharmacodynamics.2020
Pharmacodynamics.2020
 
Overview of Pharmacodynamics
Overview of PharmacodynamicsOverview of Pharmacodynamics
Overview of Pharmacodynamics
 
Bioassay.pptx
Bioassay.pptxBioassay.pptx
Bioassay.pptx
 
bioassay-converted.pptx
bioassay-converted.pptxbioassay-converted.pptx
bioassay-converted.pptx
 
Dose-Response of drugs towards the human body
Dose-Response of drugs towards the human bodyDose-Response of drugs towards the human body
Dose-Response of drugs towards the human body
 
Expt. 4 DRC of acetylcholine using frog rectus abdominis muscle
Expt. 4 DRC of acetylcholine using frog rectus abdominis muscleExpt. 4 DRC of acetylcholine using frog rectus abdominis muscle
Expt. 4 DRC of acetylcholine using frog rectus abdominis muscle
 
Ic50
Ic50Ic50
Ic50
 

More from Dr Shah Murad

Directory and other informat
Directory and other informatDirectory and other informat
Directory and other informatDr Shah Murad
 
Corticosteroids
CorticosteroidsCorticosteroids
CorticosteroidsDr Shah Murad
 
Cv my august in another format
Cv my august in another formatCv my august in another format
Cv my august in another formatDr Shah Murad
 
My article pubmed
My article pubmedMy article pubmed
My article pubmedDr Shah Murad
 
Http for songs
Http for songsHttp for songs
Http for songsDr Shah Murad
 
My Personal Phone Directory
 My Personal Phone Directory My Personal Phone Directory
My Personal Phone DirectoryDr Shah Murad
 
My Research Article
My Research ArticleMy Research Article
My Research ArticleDr Shah Murad
 
Resume of PROF DR SHAH MURAD jan 2011
Resume of PROF DR SHAH MURAD jan 2011Resume of PROF DR SHAH MURAD jan 2011
Resume of PROF DR SHAH MURAD jan 2011
Dr Shah Murad
 
Hasnain Hakro pics
Hasnain Hakro picsHasnain Hakro pics
Hasnain Hakro picsDr Shah Murad
 
Intro to pharmacology
Intro to pharmacologyIntro to pharmacology
Intro to pharmacologyDr Shah Murad
 
Cv my dec 2010
Cv my dec 2010Cv my dec 2010
Cv my dec 2010Dr Shah Murad
 
Friendz pics
Friendz picsFriendz pics
Friendz pics
Dr Shah Murad
 
My Pictures
My PicturesMy Pictures
My Pictures
Dr Shah Murad
 
Cv my nov 2010
Cv my nov 2010Cv my nov 2010
Cv my nov 2010Dr Shah Murad
 
RESUME OF PROF. DR. SHAH MURAD
RESUME OF PROF. DR. SHAH MURADRESUME OF PROF. DR. SHAH MURAD
RESUME OF PROF. DR. SHAH MURAD
Dr Shah Murad
 
CV of Prof. Dr. Shah Murad
CV of Prof. Dr. Shah MuradCV of Prof. Dr. Shah Murad
CV of Prof. Dr. Shah MuradDr Shah Murad
 
Antihyperlipidemics2
Antihyperlipidemics2Antihyperlipidemics2
Antihyperlipidemics2
Dr Shah Murad
 

More from Dr Shah Murad (20)

Directory and other informat
Directory and other informatDirectory and other informat
Directory and other informat
 
Chemo mcq's
Chemo mcq'sChemo mcq's
Chemo mcq's
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
 
Cv my august in another format
Cv my august in another formatCv my august in another format
Cv my august in another format
 
My article pubmed
My article pubmedMy article pubmed
My article pubmed
 
Http for songs
Http for songsHttp for songs
Http for songs
 
Hyperstar
HyperstarHyperstar
Hyperstar
 
My Personal Phone Directory
 My Personal Phone Directory My Personal Phone Directory
My Personal Phone Directory
 
My Research Article
My Research ArticleMy Research Article
My Research Article
 
Resume of PROF DR SHAH MURAD jan 2011
Resume of PROF DR SHAH MURAD jan 2011Resume of PROF DR SHAH MURAD jan 2011
Resume of PROF DR SHAH MURAD jan 2011
 
Hasnain Hakro pics
Hasnain Hakro picsHasnain Hakro pics
Hasnain Hakro pics
 
Intro to pharmacology
Intro to pharmacologyIntro to pharmacology
Intro to pharmacology
 
Cv my dec 2010
Cv my dec 2010Cv my dec 2010
Cv my dec 2010
 
Friendz pics
Friendz picsFriendz pics
Friendz pics
 
My Pictures
My PicturesMy Pictures
My Pictures
 
Hasnain Hakro
Hasnain HakroHasnain Hakro
Hasnain Hakro
 
Cv my nov 2010
Cv my nov 2010Cv my nov 2010
Cv my nov 2010
 
RESUME OF PROF. DR. SHAH MURAD
RESUME OF PROF. DR. SHAH MURADRESUME OF PROF. DR. SHAH MURAD
RESUME OF PROF. DR. SHAH MURAD
 
CV of Prof. Dr. Shah Murad
CV of Prof. Dr. Shah MuradCV of Prof. Dr. Shah Murad
CV of Prof. Dr. Shah Murad
 
Antihyperlipidemics2
Antihyperlipidemics2Antihyperlipidemics2
Antihyperlipidemics2
 

Recently uploaded

Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
Paul Groth
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Tobias Schneck
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Product School
 
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
Product School
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
RTTS
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Product School
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
Cheryl Hung
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
g2nightmarescribd
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
DanBrown980551
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
Product School
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
91mobiles
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Product School
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
Product School
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
Frank van Harmelen
 

Recently uploaded (20)

Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
 
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
 

Lecture 2 Dose Response Relationship 1

  • 1. Dose Response Relationship & Therapeutic Index Dr Rizwan
  • 2. quantal (cumulative) D/R curve tachyphylaxis graded (quantitative) D/R curve therapeutic index potency median toxic dose (TD50) efficacy (effectiveness) median effective dose (ED50) dose/response (D/R) Objectives
  • 3.
  • 4. Systemic description of the magnitude of the effect of a drug as a function of the dose (very low to very high)
  • 5.
  • 6.
  • 7.
  • 9.
  • 10. BIOLOGICAL STIMULUS PERCENT RECEPTOR OCCUPANCY 0% 100% BIOLOGICAL RESPONSE RECEPTOR RESERVE TRETHOLD 0% 100% Max Effect Threshold Effect Schematic representation of the relationship between threshold, receptor reserve, receptor occupancy, biological stimulus and biological response
  • 11.  
  • 12.
  • 13.
  • 14.
  • 15.  
  • 16.
  • 17.  
  • 18.
  • 19.
  • 20.  
  • 21.
  • 22. POTENCY CONCENTRATION (EC50) OR DOSE (ED50) OF A DRUG REQUIRED TO PRODUCE 50% OF THAT DRUG’S MAXIMUM EFFECT
  • 23.
  • 24.
  • 25. [D] (concentration units) % Maximal Effect 0.01 0.10 1.00 10.00 100.00 1000.00 0.0 0.2 0.4 0.6 0.8 1.0 Partial agonist Full Agonist Partial agonist PARTIAL AGONISTS - EFFICACY Even though drugs may occupy the same # of receptors, the magnitude of their effects may differ.
  • 26.  
  • 27.  
  • 28.
  • 29.
  • 30.
  • 31.
  • 32. What is the difference between Quantal and graded dose-response curves?
  • 33.
  • 34. Graded dose response curves show effects on a continuous scale And the intensity of the effect is proportional to the dose
  • 35. Exposure to ethanol Graded responses between no effect and death
  • 36.
  • 37.
  • 38. Plot of the contraction of the intestinal smooth muscle in response to varied doses of acetylcholine
  • 39.
  • 40.
  • 41.
  • 42.  
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52. BELL SHAPED CURVE majority of responders in the middle mean response is approx. 110 mg/kg fewer responders at the end of bell curve (expected) known as biological variability responders at the far left of the mean are typically hypersusceptible whereas those at the far right are resistant
  • 53.
  • 54.
  • 55.
  • 56. Cumulative quantal dose response plot
  • 57.  
  • 58.
  • 59.
  • 60.  
  • 61.  
  • 62.
  • 63. BIOLOGICAL STIMULUS PERCENT RECEPTOR OCCUPANCY 0% 100% BIOLOGICAL RESPONSE RECEPTOR RESERVE TRETHOLD 0% 100% Max Effect Threshold Effect Schematic representation of the relationship between threshold, receptor reserve, receptor occupancy, biological stimulus and biological response
  • 64.
  • 65.